News

Filter

Current filters:

AranespCardio-vascular

US FDA advisory panel backs continued use of Amgen’s Aranesp and Epogen pre-dialysis, but calls for more studies

19-10-2010

A US Food and Drug Administration advisory panel has voted near unanimously that biotech major Amgen’s…

AmgenAranespBiotechnologyCardio-vascularEpogenJohnson & JohnsonNorth AmericaOncologyPharmaceuticalProcritRegulation

Back to top